7T brain scan study for teens at risk of psychosis
Part of Brain & nervous system, Mental health clinical trials.
This trial tests how the brain’s cell membranes and energy use look in teens who are at high risk of developing psychosis. It compares them with healthy teens to better understand early brain changes that might help future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 15 to 25, at enrollment
- If in the at-risk group: meet specific assessment scores for “at risk” mental state and daily functioning
- You must be able to have a 7T MRI scan safely (no major metal/pregnancy/contrast/claustrophobia issues)
- You (and a legal representative if needed) must sign free, written consent before any study procedures
- If in the at-risk group: you should not already be in full psychosis, and you typically should not start or change antipsychotic medicine within the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks at how the brain changes in young people who are at high risk for developing psychosis. It aims to find better ways to predict and prevent psychosis by using brain imaging and thinking tests.
This study looks at brain scans and other health information to understand mental health conditions better. You may be able to join if you are a young adult or teen with early signs of mental health changes.
This study uses brain imaging to look at dopamine activity in people at high risk for psychosis. The results may help improve future treatments.
This study examines how the brain changes during late adolescence and early adulthood by taking images of your brain and looking at how it processes information. Understanding these changes may help scientists learn more about brain development and mental health.
This study tests whether a type of magnetic brain stimulation (rTMS) can help people who are at high risk for psychosis. The stimulation is personalized using a brain scan called magnetoencephalography (MEG) to target the right areas.
This study uses a special MRI scan to measure natural brain chemicals. It helps researchers understand how the brain works in healthy people, which may inform future treatments.
Hear when a new Patients With Ultra High Risk of Psychotic Transition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.